hyperacute-lung cancer vaccine
Biologicalexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2007 (NCT00420732)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hyperacute-lung cancer vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01774578 | Phase 2/Phase 3 (Phase 3) | Feb 1, 2013 | NewLink Genetics Inc |
| NCT00420732 | Phase 2 | Jan 1, 2007 | NewLink Genetics Inc |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| NewLink Genetics Inc | For profit | 2 | 2 | 2 | 2007 |
1 organizations
Page 1 / 1